Literature DB >> 10857874

Pregnancy complications and delivery practice in women with connective tissue disease and inflammatory rheumatic disease in Norway.

J F Skomsvoll1, M Ostensen, L M Irgens, V Baste.   

Abstract

OBJECTIVE: To assess possible associations between inflammatory rheumatic disease and pregnancy complications/delivery practice.
METHODS: In a population based study proportions were compared of obstetrical complications and interventions at delivery notified to the Medical Birth Registry of Norway during the years 1967-95 in women with (3,403) and without (671,221) rheumatic disease.
RESULTS: Women with rheumatic disease had significantly higher rates of preeclampsia and cesarean section. The relative risk of preeclampsia was particularly high in women with connective tissue disease in the years 1977-86. In women with inflammatory arthritides, the relative risk of preeclampsia was particularly high during 1987-95. The relative risk of cesarean section was high in all patient groups throughout the observation period and particularly in women with connective tissue disease.
CONCLUSION: High rates of preeclampsia and cesarean section in connective tissue disease pregnancies documented in a population based study emphasize the importance of monitoring and obstetrical interventions.

Entities:  

Mesh:

Year:  2000        PMID: 10857874

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  8 in total

1.  Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study.

Authors:  Ane L Rom; Chun S Wu; Jørn Olsen; Hanne Kjaergaard; Damini Jawaheer; Merete L Hetland; Mogens Vestergaard; Lina S Mørch
Journal:  Arthritis Rheumatol       Date:  2014-12       Impact factor: 10.995

2.  Obstetric and neonatal complications among women with autoimmune disease.

Authors:  Andrew Williams; Katherine Grantz; Indulaxmi Seeni; Candace Robledo; Shanshan Li; Marion Ouidir; Carrie Nobles; Pauline Mendola
Journal:  J Autoimmun       Date:  2019-05-27       Impact factor: 7.094

3.  Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register.

Authors:  Suzanne M M Verstappen; Yvonne King; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Ann Rheum Dis       Date:  2011-02-28       Impact factor: 19.103

4.  Pregnancy outcomes in adult patients with dermatomyositis and polymyositis.

Authors:  Kathleen D Kolstad; David Fiorentino; Shufeng Li; Eliza F Chakravarty; Lorinda Chung
Journal:  Semin Arthritis Rheum       Date:  2017-11-20       Impact factor: 5.532

5.  Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia.

Authors:  Kristin Palmsten; Sonia Hernández-Díaz; Bindee Kuriya; Daniel H Solomon; Soko Setoguchi
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-11       Impact factor: 4.794

6.  Maternal juvenile rheumatoid arthritis may be associated with preterm birth but not poor fetal growth.

Authors:  M A Mohamed; C Goldman; M El-Dib; H Aly
Journal:  J Perinatol       Date:  2015-12-17       Impact factor: 2.521

7.  Pregnancy outcomes of a joint obstetric and rheumatology clinic in a tertiary centre: a 2-year retrospective study of 98 pregnancies.

Authors:  Ryan Malcolm Hum; Trixy David; Yen June Lau; Hajira Iftikhar; Sue Thornber; Louise Simcox; Ian Bruce; Clare Tower; Pauline Ho
Journal:  Rheumatol Adv Pract       Date:  2022-03-28

8.  Reproductive trends in females with inflammatory joint disease.

Authors:  Marianne Wallenius; Kjell Å Salvesen; Anne K Daltveit; Johan F Skomsvoll
Journal:  BMC Pregnancy Childbirth       Date:  2016-05-31       Impact factor: 3.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.